Startup Strategies: How to Maximize the Value of Your BioPharma IP April 27, 2010

Startup Strategies: How to Maximize the Value of Your BioPharma IP

Tuesday, April 27, 2010
8:30-11:15am

Agenda
8:30-9:00 AM Registration & Networking
9:00-9:45 AM Presentation & QA: Getting the Most Bang for Your Patent Dollars
9:45-10:00 AM Break
10:00-11:00 AM Panel Discussion: Maximizing Value in Licensing Transactions and Acquisitions
11:00-11:15 AM Closing Comments

Maximizing the value of your BioPharma IP begins with being strategic about your end-game. You want to pay less and achieve more from your innovations and investments, and to minimize the risk of losing ownership or control over what's rightfully yours. The smart approach? Develop an IP strategy that considers your full potential for licensing, investment, merger and acquisition while delivering full protection for your patentable assets.

Join startup strategists from Townsend & Townsend, Aquilo Partners and SageSpring Partners to learn how companies today are managing to get more bang for their buck by developing integrated IP strategies that minimize their risks and maximize their investment value.

Our programs are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself.

Speakers
William Kezer, Partner, Townsend and Townsend and Crew LLP
Ethan Fingerman, Vice President, Acquilo Partners
Leslie Lippard, Partner, Sage Spring Partners
Moderator: Richard Hsu, Partner, Townsend and Townsend and Crew LLP

Registration
* Regular Price: $30
* Partners' Network: $20
* On-site Registration: add $10 to the above
Space is limited for this event, so early pre-registration is recommended to avoid disappointment on the day!

REGISTER: http://www.acteva.com/booking.cfm?bevaid=201837

Official Website: http://www.sjbiocenter.com/event/ev_2010Q2-MaximizeIPvalue.html